Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Complications of Diabetes Mellitus

Complications of Diabetes Mellitus

Diabetes mellitus is a chronic metabolic disorder characterized by persistent hyperglycemia due to insulin deficiency, resistance, or both. Prolonged hyperglycemia disrupts metabolic homeostasis and leads to acute and chronic complications.Acute ComplicationsAcute complications result from sudden metabolic imbalance.Diabetic ketoacidosis (DKA) mainly appears in type 1 diabetes but may also develop in type 2 diabetes, particularly under extreme stress. It arises from severe insulin deficiency,...

Diabetes: Management and Pharmacotherapy

Diabetes: Management and Pharmacotherapy

The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...

Diabetes: Symptoms, Diagnosis, and Complications

Diabetes: Symptoms, Diagnosis, and Complications

For most patients, experiencing several weeks of polyuria, polydipsia, fatigue, and significant weight loss may indicate the presence of diabetes. Furthermore, adults displaying the phenotypic appearance of type 2 diabetes (particularly those who are obese and not initially insulin-requiring), may have islet cell autoantibodies, suggesting autoimmune-mediated β cell destruction and a diagnosis of latent autoimmune diabetes of adults (LADA). The categorization of glucose homeostasis is based on...

Chronic Pancreatitis II: Collaborative Care

Chronic Pancreatitis II: Collaborative Care

The management of chronic pancreatitis is multifaceted, involving a comprehensive approach that includes thorough assessment, diagnostic testing, and a variety of management strategies.
Assessment:

Diabetes Mellitus: Overview and Type I Subtype

Diabetes Mellitus: Overview and Type I Subtype

Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...

Type II Diabetes I: Introduction

Type II Diabetes I: Introduction

Type 2 diabetes mellitus (T2DM) is a chronic metabolic disorder characterized by insulin resistance, in which target tissues such as the liver, muscle, and adipose tissue respond poorly to insulin. It is also associated with inadequate compensatory insulin secretion, where pancreatic β-cells fail to produce sufficient insulin. Together, these abnormalities lead to persistent hyperglycemia.EtiologyT2DM develops through a complex interaction of genetic predisposition and environmental or...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Atypical chemokine receptor 3 regulates synaptic removal in disease astrocytes.

Molecular neurodegeneration·2026

Same author

Investigation of microglial diversity in a LRRK2 G2019S mouse model of Parkinson's disease.

Neurobiology of disease·2024

Same author

[Physical activity adapted to the obese patients' needs: which assessments for what kind of prescription?].

Revue medicale suisse·2015

Same author

[Bariatric surgery: what is the ideal length of the preoperative track?].

Revue medicale suisse·2015

Same author

[Obesity: the forgotten disease that scares].

Revue medicale suisse·2014

Same author

[Role of the psychiatrist in the management of obesity].

Revue medicale suisse·2014

Search research articles

Related Experiment Video

Updated: Jun 13, 2026

Duodenal-Jejunal Bypass Surgery in Diet-Induced Obese Diabetic Mice

Duodenal-Jejunal Bypass Surgery in Diet-Induced Obese Diabetic Mice

Published on: October 18, 2024

[Surgery for diabetes: challenge or reality?].

¹Service d'endocrinologie, diabétologie et métabolisme, CHUV, 1011 Lausanne. vittorio.giusti@chuv.ch

Revue Medicale Suisse

|May 6, 2010

Summary

Bariatric surgery shows potential for diabetes remission by modifying the gut hormone axis. However, current research is limited by short study durations, small patient numbers, and high complication rates, necessitating further investigation.

Area of Science:

Endocrinology
Gastroenterology
Metabolic Surgery

Context:

Bariatric surgery impacts insulin sensitivity and resistance through reduced intake, malabsorption, and altered entero-insular axis activity.
The entero-insular axis, involving gut hormones like incretins, plays a crucial role in glucose homeostasis and diabetes management.

Purpose:

To explore a novel bariatric surgery protocol targeting the entero-insular axis for diabetes remission.
To achieve diabetes remission with minimal weight loss and nutritional deficits.

Summary:

New bariatric surgery protocols aim to induce diabetes remission by modulating the entero-insular axis, focusing on incretin function.
Preliminary findings suggest potential but are based on short-term, small-scale studies with significant complication rates.

More Related Videos

Sleeve Gastrectomy in Mice using Surgical Clips

Sleeve Gastrectomy in Mice using Surgical Clips

Published on: November 14, 2020

Related Experiment Videos

Last Updated: Jun 13, 2026

Duodenal-Jejunal Bypass Surgery in Diet-Induced Obese Diabetic Mice

Duodenal-Jejunal Bypass Surgery in Diet-Induced Obese Diabetic Mice

Published on: October 18, 2024

Sleeve Gastrectomy in Mice using Surgical Clips

Sleeve Gastrectomy in Mice using Surgical Clips

Published on: November 14, 2020

Further research into gastrointestinal mechanisms and incretin roles is essential before classifying surgery as a definitive metabolic treatment.

Impact:

Highlights the need for improved surgical techniques and a deeper understanding of metabolic pathways for effective diabetes treatment.
Emphasizes the potential of gastrointestinal surgery as a metabolic therapy, pending further validation and safety improvements.